---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-008157"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2022-04-01T23:59:59+00:00"
generated_at: "2026-06-26T10:04:52.853222+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Saira Ramasastry will not stand for re-election at Sangamo's 2022 annual meeting

## Summary
- Ms. Ramasastry notified the Board on March 28, 2022, of her decision not to stand for re-election.
- She has served as a director since June 2012 and is the longest tenured Board member.
- Her decision is not due to any disagreement with the Company on operations, policies, or practices.
- The annual meeting is scheduled for May 24, 2022.

## SEC filing metadata
- accession: 0001628280-22-008157
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2022-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000162828022008157/0001628280-22-008157-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000162828022008157/sgmo-20220328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-008157
- JSON: https://secwatch.observer/filing/0001628280-22-008157.json
- Plain text: https://secwatch.observer/filing/0001628280-22-008157.txt

## Key facts
- Executive change
  Saira Ramasastry departed as Director at SANGAMO THERAPEUTICS, INC.
  - Action: notified decision not to stand for re-election
  - Role: Director
  source text: On March 28, 2022, Saira Ramasastry, a member of the Board of Directors (the “Board”) of Sangamo Therapeutics, Inc. (the “Company”) since June 2012, notified the Company of her decision not to stand for re-election at the Company’s annual meeting of stockholders to be held on May 24, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1001233/000162828022008157/0001628280-22-008157-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.